Abbott Laboratories (ABT) Change in Acquisitions & Divestments (2017)
Abbott Laboratories (ABT) posted Change in Acquisitions & Divestments of $727.0 million for Q4 2017, up 1271.7% sequentially from $53.0 million in Q3 2017.
Abbott Laboratories (ABT) Change in Acquisitions & Divestments (2017) Analysis & Trends
Abbott Laboratories has reported Change in Acquisitions & Divestments for 1 years, with the latest figure at $727.0 million in Q4 2017.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $727.0 million in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $2.7 billion (changed N/A YoY) and the FY2025 annual result came in at $3.0 million, down 89.29% from the prior year.
- Change in Acquisitions & Divestments climbed to $727.0 million in Q4 2017 per ABT's latest filing, from $53.0 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $1.7 billion in Q1 2017 and troughed at $53.0 million in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 727.00 Mn |
| Dec 31, 2017 | 727.00 Mn |
| Sep 30, 2017 | 53.00 Mn |
| Sep 30, 2017 | 53.00 Mn |
| Jun 30, 2017 | 239.00 Mn |
| Jun 30, 2017 | 239.00 Mn |
| Mar 31, 2017 | 1.69 Bn |
| Mar 31, 2017 | 1.69 Bn |